Twist Bioscience: Cho proposes ~$1.8M share sale
The notice links the proposed sale to restricted stock vesting and says it includes an amount necessary to cover a tax obligation from settling a vested equity award distribution.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Twist Bioscience Corp officer Dennis H. Cho reported a proposed sale of 9,514 common shares, with an approximate aggregate market value of $1,797,040.47 and an approximate sale date of October 2, 2026. The shares are listed as acquired through restricted stock vesting on October 1, 2026. The notice states that the sale includes an amount necessary to cover a tax obligation resulting from settlement of a vested equity award distribution.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Vesting technical
attorney-in-fact regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What TWST sales did Dennis H. Cho report during the prior three months?
AI-generated analysis. How Rhea-AI works. Not financial advice.